FDA Clearance Tracker · P950032-S073
APLIGRAF
Last checked: Nov 20, 2026Latest source record: Jun 25, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Jun 25, 2013
Approved
Time to decision
35 days
Received May 21, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P950032-S073
- Device name
- APLIGRAF
- Applicant
- Organogenesis, Inc.
- Applicant location
- Canton, MA
- Received
- May 21, 2013
- Decided
- Jun 25, 2013
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P950032
Device type
- Device type
- Dressing, wound and burn, interactive (MGR)
- Device class
- Class III
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED IN CANTON, MASSACHUSETTS.
Source documents
Other decisions for Organogenesis, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K212579 · Decided May 2, 2023 · 624 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.